For example, KLK3 (prostate specific antigen, PSA) is used as a blood biomarker for prostate cancer [2], and alterations of KLK4, KLK5, and KLK6 have been suggested to play a role for breast cancer aggressiveness [3]. This evidence concerns the gene KLK3 and Familial prostate cancer.